Gene Therapy for Central Nervous System Cancer

We are exploring a new gene therapy using stem cells for patients with cancer in the central nervous system. This study aims to see if it can improve treatment outcomes for these patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Scienze dell'Invecchiamento, Neurologiche, Ortopediche e della Testa-Collo
La Massimina-Casal Lumbroso, Italy
IRCCS Foundation Istituto Neurologico Carlo Besta
U.O. Neurologia VIII - Neuro-oncologia Molecolare
Milan, Italy
Ospedale San Raffaele S.r.l.
U.O. Ematologia e Trapianto Midollo Osseo
Vimodrone, Italy
Sponsor: Genenta Science S.p.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.